Click here to get full coverage on The Importance of Early Diagnosis and Treatment in Obstructive HCM - HCPLive

The Importance of Early Diagnosis and Treatment in Obstructive HCM  HCPLive

The Importance of Early Diagnosis and Treatment in Obstructive HCM - HCPLive

Click here to get full coverage on ADP Recognizes 2026 HCM Distinction Award Winners at 41st Annual Meeting of the Minds Conference - PR Newswire

ADP Recognizes 2026 HCM Distinction Award Winners at 41st Annual Meeting of the Minds Conference  PR Newswire

ADP Recognizes 2026 HCM Distinction Award Winners at 41st Annual Meeting of the Minds Conference - PR Newswire

Click here to get full coverage on Unraveling HCM Heterogeneity Using Circulating microRNAs | JACC Baran - JACC Journals

Unraveling HCM Heterogeneity Using Circulating microRNAs | JACC Baran  JACC Journals

Unraveling HCM Heterogeneity Using Circulating microRNAs | JACC Baran - JACC Journals

Click here to get full coverage on Erika Ashauer Joins HCM PK-12 Studio - School Construction News

Erika Ashauer Joins HCM PK-12 Studio  School Construction News

Erika Ashauer Joins HCM PK-12 Studio - School Construction News

Click here to get full coverage on First-in-Human Gene Therapy for HCM Demonstrates Safety and Early Efficacy - Cleveland Clinic

First-in-Human Gene Therapy for HCM Demonstrates Safety and Early Efficacy  Cleveland Clinic

First-in-Human Gene Therapy for HCM Demonstrates Safety and Early Efficacy - Cleveland Clinic

Click here to get full coverage on Vietnam Launches Green Innovation Accelerator 2026 in HCM City to Drive a Powerful New Wave of Sustainable Travel and Business Growth Climate, Technology Innovation, and Green Economy Transformation - Travel And Tour World

Vietnam Launches Green Innovation Accelerator 2026 in HCM City to Drive a Powerful New Wave of Sustainable Travel and Business Growth Climate, Technology Innovation, and Green Economy Transformation  Travel And Tour World

Vietnam Launches Green Innovation Accelerator 2026 in HCM City to Drive a Powerful New Wave of Sustainable Travel and Business Growth Climate, Technology Innovation, and Green Economy Transformation - Travel And Tour World

Click here to get full coverage on Can Myqorzo Drive Growth for Cytokinetics Amid Competition? - Yahoo Finance Australia

Can Myqorzo Drive Growth for Cytokinetics Amid Competition?  Yahoo Finance Australia

Can Myqorzo Drive Growth for Cytokinetics Amid Competition? - Yahoo Finance Australia

Click here to get full coverage on HCM II Acquisition (NASDAQ:IMSR) Stock Price Up 7.4% - Time to Buy? - MarketBeat

HCM II Acquisition (NASDAQ:IMSR) Stock Price Up 7.4% - Time to Buy?  MarketBeat

HCM II Acquisition (NASDAQ:IMSR) Stock Price Up 7.4% - Time to Buy? - MarketBeat

Click here to get full coverage on Cytokinetics Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025 - Cytokinetics

Cytokinetics Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025  Cytokinetics

Cytokinetics Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025 - Cytokinetics

Click here to get full coverage on International study shows mavacamten monotherapy improves heart function in patients with HCM, a common inherited heart disease - The University of Alabama at Birmingham

International study shows mavacamten monotherapy improves heart function in patients with HCM, a common inherited heart disease  The University of Alabama at Birmingham

International study shows mavacamten monotherapy improves heart function in patients with HCM, a common inherited heart disease - The University of Alabama at Birmingham

Click here to get full coverage on Dayforce Inc. stock (US23920P1093): Is its HCM platform strong enough to unlock new upside? - AD HOC NEWS

Dayforce Inc. stock (US23920P1093): Is its HCM platform strong enough to unlock new upside?  AD HOC NEWS

Dayforce Inc. stock (US23920P1093): Is its HCM platform strong enough to unlock new upside? - AD HOC NEWS

Click here to get full coverage on Nonobstructive HCM Treatment: Differential Effect of Bisoprolol vs. Verapamil - American College of Cardiology

Nonobstructive HCM Treatment: Differential Effect of Bisoprolol vs. Verapamil  American College of Cardiology

Nonobstructive HCM Treatment: Differential Effect of Bisoprolol vs. Verapamil - American College of Cardiology

Click here to get full coverage on PeopleSoft HCM to be unavailable early Monday - Case Western Reserve University

PeopleSoft HCM to be unavailable early Monday  Case Western Reserve University

PeopleSoft HCM to be unavailable early Monday - Case Western Reserve University

Click here to get full coverage on SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too - TCTMD.com

SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too  TCTMD.com

SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too - TCTMD.com

Click here to get full coverage on Global trial shows targeted heart drug reduces obstructive hypertrophic cardiomyopathy in youth - Medical Xpress

Global trial shows targeted heart drug reduces obstructive hypertrophic cardiomyopathy in youth  Medical Xpress

Global trial shows targeted heart drug reduces obstructive hypertrophic cardiomyopathy in youth - Medical Xpress

Click here to get full coverage on Monitoring Treatment Response and Advancing Therapy in Obstructive HCM - HCPLive

Monitoring Treatment Response and Advancing Therapy in Obstructive HCM  HCPLive

Monitoring Treatment Response and Advancing Therapy in Obstructive HCM - HCPLive

Click here to get full coverage on Expanded effort will help standardize, improve care for hypertrophic cardiomyopathy - www.heart.org

Expanded effort will help standardize, improve care for hypertrophic cardiomyopathy  www.heart.org

Expanded effort will help standardize, improve care for hypertrophic cardiomyopathy - www.heart.org

Click here to get full coverage on HCM II Acquisition (NASDAQ:IMSR) Shares Gap Up - Here's Why - MarketBeat

HCM II Acquisition (NASDAQ:IMSR) Shares Gap Up - Here's Why  MarketBeat

HCM II Acquisition (NASDAQ:IMSR) Shares Gap Up - Here's Why - MarketBeat

Click here to get full coverage on Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine - Cytokinetics

Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine  Cytokinetics

Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine - Cytokinetics

Click here to get full coverage on Joseph Rossano, MD, discusses the benefits of mavacamten in HCM patients - Contemporary Pediatrics

Joseph Rossano, MD, discusses the benefits of mavacamten in HCM patients  Contemporary Pediatrics

Joseph Rossano, MD, discusses the benefits of mavacamten in HCM patients - Contemporary Pediatrics

Click here to get full coverage on Edgewise Therapeutics Announces Completion of the EDG-7500 CIRRUS-HCM Phase 2 Parts B and C and Favorable Interim Safety Results from the Ongoing Part D Study in Hypertrophic Cardiomyopathy - PR Newswire

Edgewise Therapeutics Announces Completion of the EDG-7500 CIRRUS-HCM Phase 2 Parts B and C and Favorable Interim Safety Results from the Ongoing Part D Study in Hypertrophic Cardiomyopathy  PR Newswire

Edgewise Therapeutics Announces Completion of the EDG-7500 CIRRUS-HCM Phase 2 Parts B and C and Favorable Interim Safety Results from the Ongoing Part D Study in Hypertrophic Cardiomyopathy - PR Newswire

Click here to get full coverage on Asymptomatic Hypertrophic Cardiomyopathy: Insights on Long-Term Outcomes and More - Cleveland Clinic

Asymptomatic Hypertrophic Cardiomyopathy: Insights on Long-Term Outcomes and More  Cleveland Clinic

Asymptomatic Hypertrophic Cardiomyopathy: Insights on Long-Term Outcomes and More - Cleveland Clinic

Click here to get full coverage on Oracle Fusion Agentic Applications for HR: What It Means for HCM Leaders - UC Today

Oracle Fusion Agentic Applications for HR: What It Means for HCM Leaders  UC Today

Oracle Fusion Agentic Applications for HR: What It Means for HCM Leaders - UC Today

Click here to get full coverage on 9 Questions to Ask Your Doctor About HCM - HealthCentral

9 Questions to Ask Your Doctor About HCM  HealthCentral

9 Questions to Ask Your Doctor About HCM - HealthCentral

Click here to get full coverage on Is Progression of Myocardial Fibrosis a Risk Indicator in HCM? - American College of Cardiology

Is Progression of Myocardial Fibrosis a Risk Indicator in HCM?  American College of Cardiology

Is Progression of Myocardial Fibrosis a Risk Indicator in HCM? - American College of Cardiology

Click here to get full coverage on Advances in feline hypertrophic cardiomyopathy (HCM): Diagnosis, management, and future directions - DVM360

Advances in feline hypertrophic cardiomyopathy (HCM): Diagnosis, management, and future directions  DVM360

Advances in feline hypertrophic cardiomyopathy (HCM): Diagnosis, management, and future directions - DVM360

Click here to get full coverage on Can You Still Have Sex With Hypertrophic Cardiomyopathy? - HealthCentral

Can You Still Have Sex With Hypertrophic Cardiomyopathy?  HealthCentral

Can You Still Have Sex With Hypertrophic Cardiomyopathy? - HealthCentral

Click here to get full coverage on Living With Hypertrophic Cardiomyopathy (HCM): Dos and Don’ts - Everyday Health

Living With Hypertrophic Cardiomyopathy (HCM): Dos and Don’ts  Everyday Health

Living With Hypertrophic Cardiomyopathy (HCM): Dos and Don’ts - Everyday Health

Click here to get full coverage on Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy - NEJM

Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy  NEJM

Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy - NEJM

Click here to get full coverage on Why Early Treatment Matters With HCM - HealthCentral

Why Early Treatment Matters With HCM  HealthCentral

Why Early Treatment Matters With HCM - HealthCentral

Click here to get full coverage on Mavacamten’s Benefits Are Not Sex-Dependent and Include Sustained Cardiac Remodeling - Cleveland Clinic

Mavacamten’s Benefits Are Not Sex-Dependent and Include Sustained Cardiac Remodeling  Cleveland Clinic

Mavacamten’s Benefits Are Not Sex-Dependent and Include Sustained Cardiac Remodeling - Cleveland Clinic

Click here to get full coverage on Myosin Inhibitor for Nonobstructive HCM: No Clinical Benefits but Positive Biomarker and Echo Effects - Cleveland Clinic

Myosin Inhibitor for Nonobstructive HCM: No Clinical Benefits but Positive Biomarker and Echo Effects  Cleveland Clinic

Myosin Inhibitor for Nonobstructive HCM: No Clinical Benefits but Positive Biomarker and Echo Effects - Cleveland Clinic

Click here to get full coverage on Behind The Science: Midventricular Obstruction in HCM - An Overlooked High Risk Phenotype - JACC Journals

Behind The Science: Midventricular Obstruction in HCM - An Overlooked High Risk Phenotype  JACC Journals

Behind The Science: Midventricular Obstruction in HCM - An Overlooked High Risk Phenotype - JACC Journals

Click here to get full coverage on Patient story: Life after HCM — Willem’s journey to an active new normal - Bristol Myers Squibb

Patient story: Life after HCM — Willem’s journey to an active new normal  Bristol Myers Squibb

Patient story: Life after HCM — Willem’s journey to an active new normal - Bristol Myers Squibb

Click here to get full coverage on Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy - NEJM

Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy  NEJM

Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy - NEJM

Click here to get full coverage on Characteristics and Long-Term Outcomes of Asymptomatic Patients With Hypertrophic Cardiomyopathy - JACC Journals

Characteristics and Long-Term Outcomes of Asymptomatic Patients With Hypertrophic Cardiomyopathy  JACC Journals

Characteristics and Long-Term Outcomes of Asymptomatic Patients With Hypertrophic Cardiomyopathy - JACC Journals

Click here to get full coverage on FDA Approves Aficamten for Obstructive HCM - TCTMD.com

FDA Approves Aficamten for Obstructive HCM  TCTMD.com

FDA Approves Aficamten for Obstructive HCM - TCTMD.com

Click here to get full coverage on Prognostic Implications of Mitral Regurgitation Across Hypertrophic Cardiomyopathy Subtypes: A Report From REVEAL-HCM Study - American Heart Association Journals

Prognostic Implications of Mitral Regurgitation Across Hypertrophic Cardiomyopathy Subtypes: A Report From REVEAL-HCM Study  American Heart Association Journals

Prognostic Implications of Mitral Regurgitation Across Hypertrophic Cardiomyopathy Subtypes: A Report From REVEAL-HCM Study - American Heart Association Journals

Click here to get full coverage on MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide - TCTMD.com

MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide  TCTMD.com

MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide - TCTMD.com

Click here to get full coverage on Genetic determinants of the phenotype in a Swedish cohort of patients with hypertrophic cardiomyopathy - Nature

Genetic determinants of the phenotype in a Swedish cohort of patients with hypertrophic cardiomyopathy  Nature

Genetic determinants of the phenotype in a Swedish cohort of patients with hypertrophic cardiomyopathy - Nature

Click here to get full coverage on New Insights About the Effects of Valsartan on Early-Stage Hypertrophic Cardiomyopathy - Cleveland Clinic

New Insights About the Effects of Valsartan on Early-Stage Hypertrophic Cardiomyopathy  Cleveland Clinic

New Insights About the Effects of Valsartan on Early-Stage Hypertrophic Cardiomyopathy - Cleveland Clinic

Click here to get full coverage on Deep-learning analysis of 3D microarchitectural remodeling in hypertrophic cardiomyopathy - Science | AAAS

Deep-learning analysis of 3D microarchitectural remodeling in hypertrophic cardiomyopathy  Science | AAAS

Deep-learning analysis of 3D microarchitectural remodeling in hypertrophic cardiomyopathy - Science | AAAS

Click here to get full coverage on What’s New in PeopleSoft’s HCM Update Image 54: Key Enhancements and Features - Oracle Blogs

What’s New in PeopleSoft’s HCM Update Image 54: Key Enhancements and Features  Oracle Blogs

What’s New in PeopleSoft’s HCM Update Image 54: Key Enhancements and Features - Oracle Blogs

Click here to get full coverage on Cardiac myosin inhibitors for the treatment of obstructive and non-obstructive HCM - Nature

Cardiac myosin inhibitors for the treatment of obstructive and non-obstructive HCM  Nature

Cardiac myosin inhibitors for the treatment of obstructive and non-obstructive HCM - Nature

Click here to get full coverage on Voices of HCM: Patient stories from across the globe - Bristol Myers Squibb

Voices of HCM: Patient stories from across the globe  Bristol Myers Squibb

Voices of HCM: Patient stories from across the globe - Bristol Myers Squibb

Click here to get full coverage on Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial - American Heart Association Journals

Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial  American Heart Association Journals

Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial - American Heart Association Journals

Click here to get full coverage on BMS reports positive results in Phase III SCOUT-HCM trial for oHCM - Clinical Trials Arena

BMS reports positive results in Phase III SCOUT-HCM trial for oHCM  Clinical Trials Arena

BMS reports positive results in Phase III SCOUT-HCM trial for oHCM - Clinical Trials Arena

Click here to get full coverage on Am I at Risk for Sudden Cardiac Death From Hypertrophic Cardiomyopathy (HCM)? - Everyday Health

Am I at Risk for Sudden Cardiac Death From Hypertrophic Cardiomyopathy (HCM)?  Everyday Health

Am I at Risk for Sudden Cardiac Death From Hypertrophic Cardiomyopathy (HCM)? - Everyday Health

Click here to get full coverage on Changing what’s possible in feline heart care: Felycin-CA1 offers hope for cats with hypertrophic cardiomyopathy - DVM360

Changing what’s possible in feline heart care: Felycin-CA1 offers hope for cats with hypertrophic cardiomyopathy  DVM360

Changing what’s possible in feline heart care: Felycin-CA1 offers hope for cats with hypertrophic cardiomyopathy - DVM360

Click here to get full coverage on The Clinical Challenge of Diagnosing Hypertrophic Cardiomyopathy at Midwest Medical Center - Clinical Advisor

The Clinical Challenge of Diagnosing Hypertrophic Cardiomyopathy at Midwest Medical Center  Clinical Advisor

The Clinical Challenge of Diagnosing Hypertrophic Cardiomyopathy at Midwest Medical Center - Clinical Advisor

Click here to get full coverage on Oracle Named a Leader in Gartner® Magic Quadrant™ for Cloud HCM Suites for 1,000+ Employee Enterprises for 10th Consecutive Year - Oracle

Oracle Named a Leader in Gartner® Magic Quadrant™ for Cloud HCM Suites for 1,000+ Employee Enterprises for 10th Consecutive Year  Oracle

Oracle Named a Leader in Gartner® Magic Quadrant™ for Cloud HCM Suites for 1,000+ Employee Enterprises for 10th Consecutive Year - Oracle

Click here to get full coverage on Gene Testing Across Phenotypes of Hypertrophic Cardiomyopathy: - JACC Journals

Gene Testing Across Phenotypes of Hypertrophic Cardiomyopathy:  JACC Journals

Gene Testing Across Phenotypes of Hypertrophic Cardiomyopathy: - JACC Journals

Click here to get full coverage on Imbria Pharmaceuticals, HCMS Team Up to Support Fortitude-HCM Trial - Diagnostic and Interventional Cardiology

Imbria Pharmaceuticals, HCMS Team Up to Support Fortitude-HCM Trial  Diagnostic and Interventional Cardiology

Imbria Pharmaceuticals, HCMS Team Up to Support Fortitude-HCM Trial - Diagnostic and Interventional Cardiology

Click here to get full coverage on HCM City firms call for stable logistics costs, lower bank lending rates - vietnamnews.vn

HCM City firms call for stable logistics costs, lower bank lending rates  vietnamnews.vn

HCM City firms call for stable logistics costs, lower bank lending rates - vietnamnews.vn

Click here to get full coverage on PeopleSoft HCM Update Image 53: Elevating User Experience with Landing Pages, Dashboards, and Modern Features - Oracle Blogs

PeopleSoft HCM Update Image 53: Elevating User Experience with Landing Pages, Dashboards, and Modern Features  Oracle Blogs

PeopleSoft HCM Update Image 53: Elevating User Experience with Landing Pages, Dashboards, and Modern Features - Oracle Blogs

Click here to get full coverage on HCM II Acquisition Q4 Earnings Call Highlights - Yahoo Finance

HCM II Acquisition Q4 Earnings Call Highlights  Yahoo Finance

HCM II Acquisition Q4 Earnings Call Highlights - Yahoo Finance

Click here to get full coverage on Cardiopulmonary Exercise Testing for Characterization of Hypertrophic Cardiomyopathy: A Meta‐Analysis - American Heart Association Journals

Cardiopulmonary Exercise Testing for Characterization of Hypertrophic Cardiomyopathy: A Meta‐Analysis  American Heart Association Journals

Cardiopulmonary Exercise Testing for Characterization of Hypertrophic Cardiomyopathy: A Meta‐Analysis - American Heart Association Journals

Click here to get full coverage on SCOUT-HCM: Mavacamten Achieves Positive Results in Adolescents with Obstructive HCM - HCPLive

SCOUT-HCM: Mavacamten Achieves Positive Results in Adolescents with Obstructive HCM  HCPLive

SCOUT-HCM: Mavacamten Achieves Positive Results in Adolescents with Obstructive HCM - HCPLive

Click here to get full coverage on 96-Week FOREST-HCM Data Support Aficamten Use in Nonobstructive HCM - HCPLive

96-Week FOREST-HCM Data Support Aficamten Use in Nonobstructive HCM  HCPLive

96-Week FOREST-HCM Data Support Aficamten Use in Nonobstructive HCM - HCPLive

Click here to get full coverage on HCM City strengthens global capital links with London Stock Exchange partnership - vietnamnews.vn

HCM City strengthens global capital links with London Stock Exchange partnership  vietnamnews.vn

HCM City strengthens global capital links with London Stock Exchange partnership - vietnamnews.vn

Click here to get full coverage on Is Hypertrophic Cardiomyopathy Genetic? Here’s What You Need To Know - Cleveland Clinic Health Essentials

Is Hypertrophic Cardiomyopathy Genetic? Here’s What You Need To Know  Cleveland Clinic Health Essentials

Is Hypertrophic Cardiomyopathy Genetic? Here’s What You Need To Know - Cleveland Clinic Health Essentials

Click here to get full coverage on Coronary Stem Cell Study Retracted; GLP-1 Drugs and HCM; Bad Heart Health of Police - MedPage Today

Coronary Stem Cell Study Retracted; GLP-1 Drugs and HCM; Bad Heart Health of Police  MedPage Today

Coronary Stem Cell Study Retracted; GLP-1 Drugs and HCM; Bad Heart Health of Police - MedPage Today

Click here to get full coverage on Can You Exercise With Hypertrophic Cardiomyopathy? - Cleveland Clinic Health Essentials

Can You Exercise With Hypertrophic Cardiomyopathy?  Cleveland Clinic Health Essentials

Can You Exercise With Hypertrophic Cardiomyopathy? - Cleveland Clinic Health Essentials

Click here to get full coverage on How to Play an Active Role in Your HCM Care - HealthCentral

How to Play an Active Role in Your HCM Care  HealthCentral

How to Play an Active Role in Your HCM Care - HealthCentral

Click here to get full coverage on Hypertrophic Cardiomyopathy and Shortness of Breath Often Go Hand-in-Hand - HealthCentral

Hypertrophic Cardiomyopathy and Shortness of Breath Often Go Hand-in-Hand  HealthCentral

Hypertrophic Cardiomyopathy and Shortness of Breath Often Go Hand-in-Hand - HealthCentral

Click here to get full coverage on How to Manage Obstructive Hypertrophic Cardiomyopathy Symptoms - Everyday Health

How to Manage Obstructive Hypertrophic Cardiomyopathy Symptoms  Everyday Health

How to Manage Obstructive Hypertrophic Cardiomyopathy Symptoms - Everyday Health

Click here to get full coverage on How Next-Generation Myosin Inhibitors Work in Hypertrophic Cardiomyopathy - HealthCentral

How Next-Generation Myosin Inhibitors Work in Hypertrophic Cardiomyopathy  HealthCentral

HCM

Price Chart

Key Statistics

Technicals

About HCM

Latest News

The Importance of Early Diagnosis and Treatment in Obstructive HCM - HCPLive

ADP Recognizes 2026 HCM Distinction Award Winners at 41st Annual Meeting of the Minds Conference - PR Newswire

Unraveling HCM Heterogeneity Using Circulating microRNAs | JACC Baran - JACC Journals

Advanced Charts

Top Gainers

Top Losers